학술논문
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine
Document Type
Article
Author
O'Connell, C.L.; Horwood, K.; Baer, M.R.; Duong, V.H.; Emadi, A.; Duerskov, A.; Hansen, J.W.; Grønbaek, K.; Saini, S.K.; Holmberg-Thyden, S.; Hadrup, S.R.; Kropf, P.; Tsao-Wei, D.; Jang, H.S.; Burgos, R.; Hostetter, G.; Jones, P.; Cowland, J.; Brinker, B.T.; Youngblood, B.A.; Issa, J.-P.; Baylin, S.B.; Siddiqi, I.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 December 2022, 28(24):5306-5316)
Subject
Language
English
ISSN
15573265
10780432
10780432